搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Oryza sativa subsp. japonica Histone H2B.2 (H2B.2) CSB-YP747763OFG
CSB-EP747763OFG
CSB-BP747763OFG
CSB-MP747763OFG
CSB-EP747763OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Quercetin 3-O-methyltransferase 1 (ROMT-9) CSB-YP747764OFG
CSB-EP747764OFG
CSB-BP747764OFG
CSB-MP747764OFG
CSB-EP747764OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Serine/threonine-protein kinase Nek3 (NEK3), partial CSB-YP747765OFG
CSB-EP747765OFG
CSB-BP747765OFG
CSB-MP747765OFG
CSB-EP747765OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Probable diaminopimelate decarboxylase, chloroplastic (LYSA) CSB-YP747766OFG
CSB-EP747766OFG
CSB-BP747766OFG
CSB-MP747766OFG
CSB-EP747766OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Expansin-A5 (EXPA5) CSB-YP747767OFG
CSB-EP747767OFG
CSB-BP747767OFG
CSB-MP747767OFG
CSB-EP747767OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Serine/threonine-protein kinase SAPK6 (SAPK6) CSB-YP747768OFG
CSB-EP747768OFG
CSB-BP747768OFG
CSB-MP747768OFG
CSB-EP747768OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Cycloartenol-C-24-methyltransferase 1 (Smt1-1) CSB-YP747769OFG
CSB-EP747769OFG
CSB-BP747769OFG
CSB-MP747769OFG
CSB-EP747769OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Beta-galactosidase 11 (Os08g0549200, LOC_Os08g43570), partial CSB-YP747770OFG
CSB-EP747770OFG
CSB-BP747770OFG
CSB-MP747770OFG
CSB-EP747770OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Zinc finger CCCH domain-containing protein 54 (Os08g0126700, LOC_Os08g03310), partial CSB-YP747771OFG
CSB-EP747771OFG
CSB-BP747771OFG
CSB-MP747771OFG
CSB-EP747771OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Adenosine monophosphate-protein transferase FICD (ficd), partial CSB-YP747772DIL1
CSB-EP747772DIL1
CSB-BP747772DIL1
CSB-MP747772DIL1
CSB-EP747772DIL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Zinc transporter ZIP5 (SLC39A5), partial CSB-YP747773HU1
CSB-EP747773HU1
CSB-BP747773HU1
CSB-MP747773HU1
CSB-EP747773HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Cysteine and histidine-rich protein 1 (CYHR1) CSB-YP747774HU
CSB-EP747774HU
CSB-BP747774HU
CSB-MP747774HU
CSB-EP747774HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Lysine-specific demethylase 7 (JHDM1D), partial CSB-YP747775HU
CSB-EP747775HU
CSB-BP747775HU
CSB-MP747775HU
CSB-EP747775HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative SMEK homolog 3 (SMEK3P), partial CSB-YP747776HU
CSB-EP747776HU
CSB-BP747776HU
CSB-MP747776HU
CSB-EP747776HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human MEF2-activating motif and SAP domain-containing transcriptional regulator (MAMSTR) CSB-YP747777HU
CSB-EP747777HU
CSB-BP747777HU
CSB-MP747777HU
CSB-EP747777HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Zinc finger protein AEBP2 (AEBP2) CSB-YP747778HU
CSB-EP747778HU
CSB-BP747778HU
CSB-MP747778HU
CSB-EP747778HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative deoxyuridine 5'-triphosphate nucleotidohydrolase-like protein FLJ16323 CSB-YP747779HU
CSB-EP747779HU
CSB-BP747779HU
CSB-MP747779HU
CSB-EP747779HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Alkylglycerol monooxygenase (AGMO), partial CSB-YP747780HU1
CSB-EP747780HU1
CSB-BP747780HU1
CSB-MP747780HU1
CSB-EP747780HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human GPS, PLAT and transmembrane domain-containing protein FLJ00285, partial CSB-YP747781HU1
CSB-EP747781HU1
CSB-BP747781HU1
CSB-MP747781HU1
CSB-EP747781HU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Bicaudal D-related protein 1 (CCDC64) CSB-YP747782HU
CSB-EP747782HU
CSB-BP747782HU
CSB-MP747782HU
CSB-EP747782HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>